Curis (CRIS) EBIT Margin Growth (5y) (2015 - 2025)
Curis (CRIS) EBIT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
193,150.00 |
| Sep 30, 2025 |
-4,620.00 |
| Jun 30, 2025 |
-7,006.00 |
| Mar 31, 2025 |
-11,366.00 |
| Dec 31, 2024 |
-4,576.00 |
| Sep 30, 2024 |
-17,415.00 |
| Jun 30, 2024 |
-19,817.00 |
| Mar 31, 2024 |
-28,320.00 |
| Dec 31, 2023 |
-26,562.00 |
| Sep 30, 2023 |
-21,117.00 |
| Jun 30, 2023 |
-21,915.00 |
| Mar 31, 2023 |
-10,472.00 |
| Dec 31, 2022 |
-13,552.00 |
| Sep 30, 2022 |
14,587.00 |
| Jun 30, 2022 |
667.00 |
| Mar 31, 2022 |
-2,930.00 |
| Dec 31, 2021 |
5,481.00 |
| Sep 30, 2021 |
124,918.00 |
| Jun 30, 2021 |
16,984.00 |
| Mar 31, 2021 |
10,824.00 |
